BioScrip Stock Price (NASDAQ:BIOS)

Add to My Stocks
$2.93 $0 (0%) BIOS stock closing price Feb 16, 2018 (Closing)
Prev Close* : $2.93
Market Cap:
$373.62M
Day Low: $2.9
52 Week Low: $1.35
Open: $2.92
Volume: -
Day High: $2.99
52 Week High: $3.39
Dividend:
0.00

Latest Stock Market News

Latest Articles

BioScrip News - From Partners

BioScrip Announces Additions to Senior Leadership Team   by Globe Newswire on Nov 28, 2017
BioScrip Reports Second Quarter 2017 Financial Results   by Globe Newswire on Aug 08, 2017

BIOS Stockcharts

View BIOS PE ratio, PS ratio stocks charts and compare with peers.
BIOS Chart
Note: Compare BioScrip stock price history with the index and industry peers.

BioScrip Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
0.42
PB ratio (
price to book ratio
)
14.49

BioScrip Returns

ROE
(return on equity)
-290%

BioScrip Financial Ratios

Asset Turnover
1.32
Receivables Turnover
8.46
Debt to Equity
332.34
Dividend Yield
0%

BIOS Industry Peers

Company Price Change (%)
Radnet (RDNT)10.050.05 (0.5%)
Addus Homecare (ADUS)35.71.05 (2.86%)
Aac Holdings (AAC)8.320.06 (0.72%)
Quorum Health (QHC)6.360.05 (0.79%)
Almost Family (AFAM)57.50.1 (0.17%)
Amedisys (AMED)56.460.72 (1.29%)
Gentiva Health Services (GTIV)19.190.23 (1.18%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Psychemedics (PMD)21.290.39 (1.87%)
Quest Diagnostics (DGX)104.531.44 (1.4%)
Amedisys (AMED)56.460.72 (1.29%)
U.S. Physical Therapy (USPH)76.10.4 (0.53%)
RadNet (RDNT)10.050.05 (0.5%)
LHC (LHCG)63.390.3 (0.48%)
Almost Family (AFAM)57.50.1 (0.17%)
Top gainers from Medical-Outpatient-Home care industry
* As of Feb 17, 2018
CompanyPriceChange (%)
Helios And Matheson Analytics (HMNY)4.740.32 (6.32%)
Addus HomeCare (ADUS)35.71.05 (2.86%)
China Cord Blood Corp (CO)10.520.2 (1.87%)
ENCOMPASS HLTH (EHC)52.10.73 (1.38%)
ENVISION HLTHCR (EVHC)37.70.37 (0.97%)
Chemed (CHE)254.560.72 (0.28%)
DAVITA INC (DVA)73.650.19 (0.26%)
Top losers from Medical-Outpatient-Home care industry
* As of Feb 17, 2018

BioScrip Inc Stock News - Partner Headlines

BioScrip Financial Statements

income statement20162015201420132012
Net Sales or Revenues935.58M982.22M984.05M842.19M662.63M
Net Income-41.5M-299.7M-147.46M-69.65M64.7M
Total Operating Expense263.7M548.55M352.14M278.78M211.66M
View BioScrip income statement
balance sheet20162015201420132012
Total Assets607.74M546.5M824.71M936.85M642.37M
Total Liabilities567.3M564.46M607.9M582.27M348.96M
Shareholders Equity40.43M-17.96M216.8M354.58M293.4M
View BioScrip balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-11.43M-21.28M75.74M-32.43M38.19M
Net Cash from (used by) Operating Activities-42.76M-64.74M-31.41M-54.55M26.88M
Increase (Decrease) in Prop Plant And Equipment-5.46M-11.54M-13.82M-25.62M-10.98M
View BioScrip cash flow statement

BioScrip Stock Message Board

BioScrip stock price ended the last trading day at $2.93. Looking at BioScrip market capitalization, which currently stands at $373.62M, we can say that BIOS stock is a Small Cap stock. A value investor must look at the fundamentals of a stock, and perform BioScrip valuation, even though in the short-term, sentiment and current breaking news might affect BioScrip stock price.

For recognizing and analyzing the real performance of BioScrip stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in BioScrip stock quote data shows the number of shares traded. For Ex: 395,112 BioScrip shares were traded as of last trading day, as seen from BioScrip stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. BioScrip dividend per share was 0.00 during the last quarter. BioScrip stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.